Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Get email alerts on the Rulemaking Outsourcing topic
No spam. Unsubscribe anytime.
Board unanimously rescinds 2022 rulemaking initiation for outsourcing‑facility regulations
Summary
The California State Board of Pharmacy voted unanimously on June 10 to resend its October 26, 2022 motion to initiate rulemaking to add sections 1750 and 1750.1 to Title 16, CCR because statutory changes have superseded parts of the proposed regulation.
The California State Board of Pharmacy voted unanimously on June 10 to rescind its October 26, 2022 motion to initiate rulemaking for sections 1750 and 1750.1 of Title 16 of the California Code of Regulations, a step staff recommended after statutory changes made portions of the proposed regulatory text unnecessary.
Staff said the earlier regulation text addressed authority for outsourcing facilities electing to dispense patient‑specific compounded preparations and established a self‑assessment process. Since that 2022 action, statutory changes have created the self‑assessment requirement in statute, reducing the need for some regulatory provisions. Board staff proposed rescinding the prior action; Jesse moved and Ricardo seconded the motion. The board conducted a roll‑call vote; all members present voted yes and the motion passed.
The board’s motion will remove the prior formal initiation of the rulemaking from the board’s active rulemaking agenda. Staff will reflect the board’s direction in its regulatory-tracking materials and proceed according to updated statutory context.
